MIRM

90.17

2.61% 2.29

Handel nachbörslich: 90.17

Mirum Pharmaceuticals Inc (MIRM)

Überblick Nachrichten Preisverlauf Optionskette Financials Warum fällt MIRM? Forum Prognose

Schlusskurs vom Vortag:

$87.88

Offen:

$88.89

24-Stunden-Volumen:

614.12K

Relative Volume:

0.72

Marktkapitalisierung:

$5.44B

Einnahmen:

$521.31M

Nettoeinkommen (Verlust:

$-23.36M

KGV:

-188.60

EPS:

-0.4781

Netto-Cashflow:

$54.87M

1W Leistung:

-1.63%

1M Leistung:

-16.99%

6M Leistung:

+22.56%

1J Leistung:

+91.61%

1-Tages-Spanne:

$88.35

$91.73

1-Wochen-Bereich:

$84.94

$94.16

52-Wochen-Spanne:

$36.88

$109.28

Mirum Pharmaceuticals Inc Stock (MIRM) Company Profile

Firmenname

Mirum Pharmaceuticals Inc

Sektor

Healthcare (1114)

Branche

Biotechnology (623)

Telefon

650-667-4085

Adresse

989 EAST HILLSDALE BOULEVARD, SUITE 300, FOSTER CITY

Mitarbeiter

372

Twitter

@mirumpharma

Nächster Verdiensttermin

2024-11-04

Neueste SEC-Einreichungen

MIRM's Discussions on Twitter

Compare MIRM vs VRTX, REGN, ALNY, ARGX, INSM

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
MIRM Mirum Pharmaceuticals Inc	90.17	5.30B	521.31M	-23.36M	54.87M	-0.4781
VRTX Vertex Pharmaceuticals Inc	454.97	113.96B	12.07B	3.95B	3.19B	15.33
REGN Regeneron Pharmaceuticals Inc	749.47	78.41B	14.34B	4.50B	3.77B	41.56
ALNY Alnylam Pharmaceuticals Inc	328.70	40.85B	3.71B	313.75M	465.38M	2.2571
ARGX Argen X Se Adr	697.05	42.05B	4.16B	1.29B	734.26M	19.58
INSM Insmed Inc	148.31	29.99B	606.42M	-1.28B	-997.58M	-6.403

Mirum Pharmaceuticals Inc Stock (MIRM) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2026-02-18	Eingeleitet	RBC Capital Mkts	Outperform
2025-09-24	Eingeleitet	TD Cowen	Buy
2025-08-11	Fortgesetzt	Stifel	Buy
2025-05-19	Fortgesetzt	H.C. Wainwright	Buy
2024-04-17	Eingeleitet	Stifel	Buy
2023-12-18	Bestätigt	H.C. Wainwright	Buy
2023-11-20	Fortgesetzt	JP Morgan	Overweight
2023-11-13	Eingeleitet	Morgan Stanley	Overweight
2023-10-24	Eingeleitet	Cantor Fitzgerald	Overweight
2023-10-17	Fortgesetzt	Evercore ISI	Outperform
2023-09-20	Eingeleitet	JMP Securities	Mkt Outperform
2022-09-01	Eingeleitet	Citigroup	Buy
2021-09-20	Eingeleitet	JP Morgan	Overweight
2020-08-07	Hochstufung	Raymond James	Outperform → Strong Buy
2020-08-03	Eingeleitet	H.C. Wainwright	Buy
2020-07-31	Eingeleitet	Piper Sandler	Overweight
2020-06-25	Eingeleitet	Robert W. Baird	Outperform
2019-08-12	Eingeleitet	Citigroup	Buy
2019-08-12	Eingeleitet	Evercore ISI	Outperform
2019-08-12	Eingeleitet	Guggenheim	Buy
2019-08-12	Eingeleitet	ROTH Capital	Buy
2019-08-12	Eingeleitet	Raymond James	Outperform

Alle ansehen

Mirum Pharmaceuticals Inc Aktie (MIRM) Neueste Nachrichten

04:39 AM

Investor Mood: What are analysts price targets for Mirum Pharmaceuticals Inc2026 Institutional Moves & High Accuracy Trade Alerts - baoquankhu1.vn

04:39 AM

Mar 23, 2026

Mirum completes enrollment & screening in liver disease studies - MSN

Mar 23, 2026

Citizens reiterates Mirum Pharmaceuticals stock rating ahead of data By Investing.com - Investing.com Canada

Mar 23, 2026

Mirum Pharmaceuticals (NASDAQ:MIRM) Receives Buy Rating from HC Wainwright - MarketBeat

Mar 23, 2026

Mirum Gains 35% in 3 Months: How Should You Play the Stock? - MSN

Mar 23, 2026

Is Mirum Pharmaceuticals (NASDAQ:MIRM) Stabilizing After Rating Updates? - Kalkine Media

Mar 23, 2026

Mar 22, 2026

Mirum Pharmaceuticals (MIRM) completes enrollment for phase 3 EXPAND study of LIVMARLI - MSN

Mar 22, 2026

Mar 21, 2026

Baird updates Mirum Pharmaceuticals (MIRM) valuation following beat-and-raise earnings results - MSN

Mar 21, 2026

Mar 20, 2026

Biotech Stock Up 372% Gets Sold as New Pick Rises 40% in 2026 - The Motley Fool

Mar 20, 2026

Mirum Pharmaceuticals (MIRM) Completes Enrollment for Phase 3 EXPAND Study of LIVMARLI - Insider Monkey

Mar 20, 2026

Responsive Playbooks and the MIRM Inflection - Stock Traders Daily

Mar 20, 2026

MIRM Stock Price, Quote & Chart | MIRUM PHARMACEUTICALS INC (NASDAQ:MIRM) - ChartMill

Mar 20, 2026

Mar 19, 2026

MIRM SEC FilingsMirum Pharmaceuticals 10-K, 10-Q, 8-K Forms - Stock Titan

Mar 19, 2026

5 Most Promising Stocks Under $100 to Buy - Insider Monkey

Mar 19, 2026

Mar 18, 2026

RBC Capital initiates coverage of Mirum Pharmaceuticals (MIRM) with outperform recommendation - MSN

Mar 18, 2026

Why Mirum Pharmaceuticals Stock Is Sinking Today - TipRanks

Mar 18, 2026

Penn Capital Management Company LLC Sells 34,265 Shares of Mirum Pharmaceuticals, Inc. $MIRM - MarketBeat

Mar 18, 2026

Mirum EXPAND Enrollment Milestone Highlights LIVMARLI Upside And Valuation Gap - Yahoo Finance

Mar 18, 2026

Mar 17, 2026

Mirum Pharmaceuticals (NASDAQ:MIRM) Insider Joanne Quan Sells 7,287 Shares - MarketBeat

Mar 17, 2026

Insider Selling: Mirum Pharmaceuticals (NASDAQ:MIRM) COO Sells 16,515 Shares of Stock - MarketBeat

Mar 17, 2026

Insider Selling: Mirum Pharmaceuticals (NASDAQ:MIRM) CFO Sells $670,258.26 in Stock - MarketBeat

Mar 17, 2026

Mirum Pharma’s chief medical officer Quan sells $670k in stock - Investing.com Canada

Mar 17, 2026

Mirum Pharmaceuticals Executives Sell Shares - TradingView

Mar 17, 2026

Mirum (NASDAQ: MIRM) CFO exercises performance RSUs, sells shares to cover tax withholding - Stock Titan

Mar 17, 2026

Mirum (MIRM) CMO exercises performance RSUs, sells 7,287 shares for tax - Stock Titan

Mar 17, 2026

[Form 4] Mirum Pharmaceuticals, Inc. In... - Stock Titan

Mar 17, 2026

Mirum (MIRM) president sells 16,515 shares, exercises 30,220 RSUs - Stock Titan

Mar 17, 2026

Mirum (NASDAQ: MIRM) SVP exercises PRSUs, sells 4,732 shares for taxes - Stock Titan

Mar 17, 2026

Mirum (MIRM) CEO sells shares to cover tax from RSU vesting - Stock Titan

Mar 17, 2026

Mirum Pharmaceuticals (NASDAQ: MIRM) files to sell 7,287 vested RSU shares - Stock Titan

Mar 17, 2026

Joanne Quan to Sell 7,287 Mirum Shares (NASDAQ: MIRM) via Morgan Stanley - Stock Titan

Mar 17, 2026

Mirum Pharmaceuticals (NASDAQ: MIRM) insider files to sell 16,515 shares - Stock Titan

Mar 17, 2026

Mirum Pharmaceuticals (MIRM) files Form 144: proposed resale of vested RSUs - Stock Titan

Mar 17, 2026

Mirum Pharmaceuticals (NASDAQ: MIRM) insider sells vested RSUs totaling multiple transactions - Stock Titan

Mar 17, 2026

Mirum Completes Enrollment in Late-Stage EXPAND Study of Livmarli - The Globe and Mail

Mar 17, 2026

Citizens reiterates Mirum Pharmaceuticals stock rating on trial progress - Investing.com

Mar 17, 2026

Aquatic Capital Management LLC Boosts Stock Holdings in Mirum Pharmaceuticals, Inc. $MIRM - MarketBeat

Mar 17, 2026

Mirum completes enrollment in cholestatic pruritus trial By Investing.com - Investing.com India

Mar 17, 2026

Mar 16, 2026

Trading Recap: Is Mirum Pharmaceuticals Inc a turnaround story2026 Breakouts & Breakdowns & Fast Gain Stock Tips - baoquankhu1.vn

Mar 16, 2026

Mirum Pharmaceuticals releases latest announcement details - Traders Union

Mar 16, 2026

Saira Ramasastry to sell 2,000 shares via option exercise (NASDAQ: MIRM) - Stock Titan

Mar 16, 2026

Mirum Pharmaceuticals Completes Enrollment in Phase 3 EXPAND Study of LIVMARLI® (maralixibat) in Additional Rare Cholestatic Liver Diseases - BioSpace

Mar 16, 2026

Mirum completes enrollment in cholestatic pruritus trial - Investing.com

Mar 16, 2026

Algert Global LLC Buys 31,250 Shares of Mirum Pharmaceuticals, Inc. $MIRM - MarketBeat

Mar 16, 2026

Mar 15, 2026

Eventide Asset Management LLC Sells 114,922 Shares of Mirum Pharmaceuticals, Inc. $MIRM - MarketBeat

Mar 15, 2026